Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight

ClinicalTrials.gov ID: NCT06124807

Public ClinicalTrials.gov record NCT06124807. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 9:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Parallel-Group, Double-Blind, 4-Arm Study to Investigate Weight Management With LY3305677 Compared With Placebo and in Adult Participants With Obesity or Overweight

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study, performed under a master protocol W8M-MC-CWMM (NCT06143956), is to investigate weight management efficacy and safety with Mazdutide compared with placebo and in adult participants with obesity or overweight. The study will last about 62 weeks.

Study identification

NCT ID
NCT06124807
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
179 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 16, 2023
Primary completion
Jan 21, 2025
Completion
Jul 8, 2025
Last update posted
Apr 20, 2026

2023 – 2025

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa Chandler Arizona 85225
Headlands Research - Scottsdale Scottsdale Arizona 85260
The Institute for Liver Health II dba Arizona Liver Health-Tucson Tucson Arizona 85712
Velocity Clinical Research, Huntington Park Huntington Park California 90255
Peninsula Research Associates Rolling Hills Estates California 90274
Diablo Clinical Research, Inc. Walnut Creek California 94598
Northeast Research Institute (NERI) Fleming Island Florida 32003
Suncoast Clinical Research, Inc. New Port Richey Florida 34652
Charter Research - Winter Park Orlando Florida 32803
Charter Research - Lady Lake The Villages Florida 32162
Pacific Diabetes & Endocrine Center Honolulu Hawaii 96817
Great Lakes Clinical Trials - Andersonville Chicago Illinois 60640
Great Lakes Clinical Trials - Ravenswood Chicago Illinois 60640
Cotton O'Neil Diabetes & Endocrinology Topeka Kansas 66606
L-MARC Research Center Louisville Kentucky 40213
Knownwell Needham Massachusetts 02492
StudyMetrix Research City of Saint Peters Missouri 63303
Las Vegas Medical Research Las Vegas Nevada 89128
Dent Neurologic Institute Amherst New York 14226
North Suffolk Neurology Port Jefferson Station New York 11776
Lucas Research, Inc. New Bern North Carolina 28562
CTI Clinical Research Center Cincinnati Ohio 45212
Quality Medical Research Nashville Tennessee 37211
IMA Clinical Research Austin Austin Texas 78745
Velocity Clinical Research, Dallas Dallas Texas 75230
PlanIt Research, PLLC Houston Texas 77079
Tekton Research - Fredericksburg Road San Antonio Texas 78229
Spectrum Medical, Inc. Danville Virginia 24541
Central Washington Health Services Association d/b/a Confluence Health Wenatchee Washington 98801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06124807, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06124807 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →